Bayer, DE000BAY0017

Bayer stock after-hours at EUR 44.91: minus 0.93 percent versus prior close

Published on 10/02/2026 at 19:28 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS

Bayer stock was at EUR 44.91 after-hours on October 2, 2026, down 0.93 percent versus the Lang & Schwarz prior close. The quote was recorded at 7:22 p.m. CEST.

Architektur-Render eines modernen glĂ€sernen Forschungscampus mit GrĂŒnflĂ€chen
Bayer AG (DE000BAY0017): modernes Architektur-Render eines glĂ€sernen Pharma-Forschungscampus mit GrĂŒnflĂ€chen bei strahlendem Tageslicht, Illustration mit AI erstellt.

Bayer stock was at EUR 44.91 after-hours on October 2, 2026, down 0.93 percent versus the prior close at Lang & Schwarz. The quote was recorded at 7:22 p.m. CEST.

After-hours trading

The prior close at Lang & Schwarz was EUR 45.33. The quoted bid was EUR 44.79 and the ask was EUR 45.02. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bayer stock.

Bayer appoints chief medical officer

Bayer announced on October 1, 2026, that Dr. Christoph Koenen had been appointed chief medical officer effective that day. He will lead medical and scientific strategies across the organization in addition to his existing role as head of clinical development and operations in Bayer’s Pharmaceuticals Division.

Bayer said the appointment is intended to reinforce patient needs and patient safety in medical and scientific decision-making throughout the product lifecycle. The company said it is advancing around 30 projects in clinical development.

Disclaimer...

en | DE000BAY0017 | BAYER | boerse | 70217322 | bgmi